【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 10
2 Introduction 11
2.1 Pancreatic Cancer Overview 11
3 Products under Development 12
3.1 Pancreatic Cancer – Pipeline Products by Stage of Development 12
3.2 Pancreatic Cancer – Pipeline Products by Territory 13
3.3 Pancreatic Cancer – Pipeline Products by Regulatory Path 14
3.4 Pancreatic Cancer – Pipeline Products by Estimated Approval Date 15
4 Pancreatic Cancer – Pipeline Products under Development by Companies 16
4.1 Pancreatic Cancer Companies – Pipeline Products by Stage of Development 16
4.2 Pancreatic Cancer – Pipeline Products by Stage of Development 19
5 Pancreatic Cancer Companies and Product Overview 21
5.1 A&G Pharmaceutical, Inc. Company Overview 21
5.1.1 A&G Pharmaceutical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.2 Abcodia Ltd. Company Overview 23
5.2.1 Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview 23
5.3 Acobiom Company Overview 24
5.3.1 Acobiom Pipeline Products & Ongoing Clinical Trials Overview 24
5.4 Andraka Technologies, LLC Company Overview 25
5.4.1 Andraka Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
5.5 Applied Proteomics, Inc. Company Overview 26
5.5.1 Applied Proteomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 Asuragen, Inc. Company Overview 27
5.6.1 Asuragen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 BioMarker Strategies, LLC Company Overview 28
5.7.1 BioMarker Strategies, LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 Biouniversa s.r.l. Company Overview 29
5.8.1 Biouniversa s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 29
5.9 Cancer Research Technology Limited Company Overview 31
5.9.1 Cancer Research Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 Cellmid Limited Company Overview 32
5.10.1 Cellmid Limited Pipeline Products & Ongoing Clinical Trials Overview 32
5.11 Cepheid Company Overview 33
5.11.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 33
5.12 Chronix Biomedical, Inc. Company Overview 35
5.12.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.13 Cleveland Diagnostics Inc. Company Overview 37
5.13.1 Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.14 Clovis Oncology, Inc. Company Overview 38
5.14.1 Clovis Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
5.15 CompanDX Ltd. Company Overview 40
5.15.1 CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
5.16 Courtagen Life Sciences, Inc. Company Overview 41
5.16.1 Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.17 CS-Keys, Inc. Company Overview 42
5.17.1 CS-Keys, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.18 Dartmouth College Company Overview 43
5.18.1 Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 43
5.19 Di.V.A.L Toscana srl Company Overview 45
5.19.1 Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview 45
5.20 Exact Sciences Corporation Company Overview 46
5.20.1 Exact Sciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 46
5.21 GeneFluidics Inc. Company Overview 48
5.21.1 GeneFluidics Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.22 German Cancer Research Center Company Overview 49
5.22.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 49
5.23 GlycoZym Company Overview 50
5.23.1 GlycoZym Pipeline Products & Ongoing Clinical Trials Overview 50
5.24 Health Discovery Corporation Company Overview 51
5.24.1 Health Discovery Corporation Pipeline Products & Ongoing Clinical Trials Overview 51
5.25 Hebrew University of Jerusalem Company Overview 53
5.25.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 53
5.26 ImmunoCellular Therapeutics, Ltd. Company Overview 54
5.26.1 ImmunoCellular Therapeutics, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 54
5.27 Immunomedics, Inc. Company Overview 56
5.27.1 Immunomedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
5.28 Imperial College London Company Overview 58
5.28.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 58
5.29 IV Diagnostics, Inc. Company Overview 59
5.29.1 IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.30 Matrix-Bio, Inc. Company Overview 60
5.30.1 Matrix-Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.31 Mayo Clinic Company Overview 61
5.31.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 61
5.32 MDNA Life Sciences, Inc. Company Overview 62
5.32.1 MDNA Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.33 Merrimack Pharmaceuticals, Inc. Company Overview 63
5.33.1 Merrimack Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
5.34 Metanomics Health GmbH Company Overview 65
5.34.1 Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 65
5.35 Milagen, Inc. Company Overview 66
5.35.1 Milagen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.36 Miraculins Inc. Company Overview 67
5.36.1 Miraculins Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.37 NanoScale Corporation Company Overview 69
5.37.1 NanoScale Corporation Pipeline Products & Ongoing Clinical Trials Overview 69
5.38 NatiMab Therapeutics S.r.l. Company Overview 70
5.38.1 NatiMab Therapeutics S.r.l. Pipeline Products & Ongoing Clinical Trials Overview 70
5.39 National Cheng-Kung University Hospital Company Overview 71
5.39.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 71
5.40 Neogenix Oncology, Inc. Company Overview 72
5.40.1 Neogenix Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.41 Onconome, Inc. Company Overview 73
5.41.1 Onconome, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
5.42 OPKO Health, Inc. Company Overview 75
5.42.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.43 Oxford Gene Technology Limited Company Overview 77
5.43.1 Oxford Gene Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 77
5.44 PeriRx LLC Company Overview 78
5.44.1 PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview 78
5.45 Precision Biologics, Inc. Company Overview 79
5.45.1 Precision Biologics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.46 Proplex Technologies, Llc Company Overview 80
5.46.1 Proplex Technologies, Llc Pipeline Products & Ongoing Clinical Trials Overview 80
5.47 Protagen AG Company Overview 82
5.47.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 82
5.48 SDIX, LLC Company Overview 83
5.48.1 SDIX, LLC Pipeline Products & Ongoing Clinical Trials Overview 83
5.49 Sienna Cancer Diagnostics Ltd Company Overview 85
5.49.1 Sienna Cancer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 85
5.50 SomaLogic, Inc. Company Overview 86
5.50.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
5.51 Source MDx Company Overview 87
5.51.1 Source MDx Pipeline Products & Ongoing Clinical Trials Overview 87
5.52 Stanford University Company Overview 88
5.52.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 88
5.53 The Johns Hopkins University Company Overview 89
5.53.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 89
5.54 Thomas Jefferson University Company Overview 93
5.54.1 Thomas Jefferson University Pipeline Products & Ongoing Clinical Trials Overview 93
5.55 US Biomarkers, Inc. Company Overview 94
5.55.1 US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 94
5.56 Viomics Inc. Company Overview 95
5.56.1 Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.57 Vitatex Inc. Company Overview 96
5.57.1 Vitatex Inc. Pipeline Products & Ongoing Clinical Trials Overview 96
5.58 VolitionRX Ltd. Company Overview 98
5.58.1 VolitionRX Ltd. Pipeline Products & Ongoing Clinical Trials Overview 98
6 Pancreatic Cancer- Recent Developments 100
7 Appendix 104
7.1 Methodology 104
7.2 About GlobalData 106
7.3 Contact Us 107
7.4 Disclaimer 107
【レポート販売概要】
■ タイトル：世界における膵臓癌検査製品のパイプライン動向2015■ 英文：Pancreatic Cancer - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0072EPD
■ 調査対象地域：グローバル
- 1-デセンの世界市場分析：用途別（ポリアルファオレフィン（PAO）、洗剤用アルコール、ポリエチレン）、セグメント予測The global demand for the 1-decene market is expected to reach USD 1.29 billion by 2025, according to a new report by Grand View Research, Inc. 1-decene (C-10), an industrially important linear alpha olefin, has observed staggering demand from synthetic lubricant manufacturers in the form of poly alpha olefin (PAO). PAO produced using 1-decene being the purest form finds high demand and the trend …
- Esophageal Cancer：グローバル臨床試験レビューH2, 2013Esophageal Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Esophageal Cancer Global Clinical Trials Review, H2, 2013" provides data on the Esophageal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Esophageal Cancer. It includes an overview of the trial numbers and their recruitment s …
- 拡張現実市場分析と予測（Augmented Reality: Global Market Analysis and Forecast 2012 – 2017）Augmented Reality (AR) is a live, direct or indirect, view of a physical, real-world environment whose elements are augmented by computer-generated sensory input, that enrich the user's perception of the real world. Although AR is often perceived to be in the visual domain (video or graphics etc), it actually includes the other senses as well such as sound or GPS data. The popularity of smartphone …
- 冷凍機（チラー）の世界市場：スクリュー冷凍機、スクロール冷凍機、遠心冷凍機、吸収式冷凍機、往復式冷凍機The global chillers market size is estimated to reach USD 10.84 Billion by 2021 at a CAGR of 4.24%. The chillers market is driven by the increasing process cooling needs in industrial applications and stringent environmental regulations driving the demand for chillers. Moreover, factors such as increasing population and rising consumption of frozen food are also contributing significantly to the i …
- 長期介護用ソフトウェアの世界市場The global long-term care software market is expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $7,561.9 million by 2019. The factors such as rise in aging population that triggers the demand for healthcare IT solutions in LTC facilities, dearth of skilled nursing personnel, and increasing healthcare reforms and government initiatives across …
- 手術室用装置/用品の世界市場：麻酔機械、手術台、電気手術ユニット、マルチパラメータ患者モニタ、手術用画像デバイス、手術室照明The operating room equipment & supplies market is expected to reach USD 29.15 Billion in 2020 from USD 24.31 Billion in 2015, growing at a CAGR of 3.7%. The global market is segmented on the basis of product, type, and end user. By product, the market is categorized into operating room supplies and operating room equipment. The operating room supplies are estimated to account for the largest share …
- 世界の水・廃水処理装置市場動向（2012-2016）TechNavio's analysts forecast the Global Water and Wastewater Treatment Equipment market to grow at a CAGR of 10.53 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing price of purchasing and using fresh water. The Global Water and Wastewater Treatment Equipment market has also been witnessing an increased water demand, leading to a major …
- 世界の手術台市場動向（2012-2016）TechNavio's analysts forecast the Global Operating Tables market to grow at a CAGR of 3.95 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in complex surgical procedures. The Global Operating Tables market has also been witnessing an increase in medical tourism. However, increasing budgetary constraints could pose a challenge to the grow …
- BRIC（ブラジル/ロシア/インド/中国）の美顔レーザー・エネルギー装置市場BRIC Aesthetic Lasers and Energy Devices Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Aesthetic Lasers and Energy Devices Market Outlook to 2020", provides key market data on the BRIC Aesthetic Lasers and Energy Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Invasive Body Contourin …
- 機能性食品成分の世界市場：プレバイオティクス、プロバイオティクス、たんぱく質、ミネラル、ビタミン、カロテノイド、繊維、植物性化学物質The nutraceutical ingredients market is emerging with the growing life expectancy and health consciousness among consumers. However, the high cost involved in R&D activities is restraining the growth of the market. Continuous development in countries such as Brazil, India, and China is paving new opportunities for the nutraceutical ingredients market. The nutraceutical ingredients market is segmen …
- 石油＆ガスにおけるパイプライン及び輸送自動化の世界市場予測・分析2020-2024Global Oil and Gas Pipeline and Transportation Automation Market: About this market Technavio’s oil and gas pipeline and transportation automation market analysis considers sales from pipeline and LNG and terminal applications. Our study also finds the sales of oil and gas pipeline and transportation automation in APAC, Europe, MEA, North America, and South America. In 2019, the pipeline segment h …
- 世界の占有センサー市場2015The Global Occupancy Sensors Industry Report 2015 is a professional and in-depth study on the current state of the Occupancy Sensors industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Occupancy Sensors market analysis is provided for the international markets including development trends, competitive …
- グリッドスケール電力貯蔵システムの世界市場：揚水発電、先進バッテリー、フライホイールAbout Grid-scale Energy Storage System Grid-scale energy storage system generally refers to the technologies that are being used for the purpose of energy storage, and this energy can be utilized in the future during power shortages, blackouts, or during high demand for power supply. This system mainly includes pumped hydro storage systems, advanced batteries, flywheel, and other evolving technolo …
- 次世代ネットワークOSS/BSS市場と展望2013-2018（Next Generation Network OSS/BSS Market and Forecast 2013-2018）NGN promises a high quality end-user experience. Telecommunications service providers expect the NGN framework to provide them with tools that would ensure customer loyalty. However, the path towards achieving the ideal NGN is fraught with formidable challenges. The most critical challenge confronting operators is optimizing their OSS and BSS platforms, systems, and processes. With research beginn …
- 統合職場管理システム（IWMS）の世界市場予測（～2021）MarketsandMarkets forecast the Integrated Workplace Management System (IWMS) market size to grow from USD 1.52 Billion in 2016 to USD 3.35 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 17.1%. Strict mandates of regulatory bodies have led the organizations to upgrade to the upcoming technological solutions to meet the quality and environment protection norms. This acts as a primary dr …
